News
Caplin Point Laboratories consolidated net profit rises 18.08% in the September 2025 quarter
05-Nov-2025 | 15:00
Sales rise 10.54% to Rs 534.04 crore
Net profit of Caplin Point Laboratories rose 18.08% to Rs 154.45 crore in the quarter ended September 2025 as against Rs 130.80 crore during the previous quarter ended September 2024. Sales rose 10.54% to Rs 534.04 crore in the quarter ended September 2025 as against Rs 483.10 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 534.04 | 483.10 | 11 |
| OPM % | 35.42 | 34.08 | - |
| PBDT | 219.40 | 185.22 | 18 |
| PBT | 201.00 | 168.46 | 19 |
| NP | 154.45 | 130.80 | 18 |
Powered by Capital Market - Live News